IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $458,000 | +129.0% | 5,388 | -4.4% | 0.00% | +100.0% |
Q2 2020 | $200,000 | -86.8% | 5,634 | -95.0% | 0.00% | -87.5% |
Q1 2020 | $1,519,000 | -34.5% | 112,684 | +2.8% | 0.01% | -11.1% |
Q4 2019 | $2,319,000 | +58.2% | 109,598 | -0.8% | 0.01% | +50.0% |
Q3 2019 | $1,466,000 | -5.1% | 110,522 | -0.7% | 0.01% | 0.0% |
Q2 2019 | $1,544,000 | -15.9% | 111,291 | +16.4% | 0.01% | -14.3% |
Q1 2019 | $1,837,000 | +32.9% | 95,640 | -1.3% | 0.01% | +16.7% |
Q4 2018 | $1,382,000 | -29.6% | 96,876 | +2.7% | 0.01% | -14.3% |
Q3 2018 | $1,964,000 | -3.3% | 94,284 | +9.8% | 0.01% | 0.0% |
Q2 2018 | $2,032,000 | +112.8% | 85,863 | +31.4% | 0.01% | +133.3% |
Q1 2018 | $955,000 | -14.2% | 65,343 | -5.1% | 0.00% | -25.0% |
Q4 2017 | $1,113,000 | +16.2% | 68,857 | +0.5% | 0.00% | +33.3% |
Q3 2017 | $958,000 | +71.1% | 68,533 | +8.1% | 0.00% | +50.0% |
Q2 2017 | $560,000 | +46.6% | 63,408 | +7.3% | 0.00% | +100.0% |
Q1 2017 | $382,000 | +107.6% | 59,094 | +17.8% | 0.00% | 0.0% |
Q4 2016 | $184,000 | -99.9% | 50,184 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $163,521,000 | +40.3% | 50,314 | +0.2% | 0.00% | – |
Q2 2016 | $116,550,000 | -17.3% | 50,237 | -11.1% | 0.00% | -100.0% |
Q1 2016 | $141,000,000 | -18.5% | 56,498 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $173,000,000 | +178250.5% | 56,498 | -0.2% | 0.00% | – |
Q3 2015 | $97,000 | -100.0% | 56,596 | -52.7% | 0.00% | -100.0% |
Q2 2015 | $485,666,000 | +143.9% | 119,622 | +130.1% | 0.00% | +100.0% |
Q1 2015 | $199,129,000 | -22.6% | 51,992 | -3.0% | 0.00% | 0.0% |
Q4 2014 | $257,300,000 | +24.3% | 53,604 | -3.7% | 0.00% | 0.0% |
Q3 2014 | $207,063,000 | +1.8% | 55,662 | -0.1% | 0.00% | 0.0% |
Q2 2014 | $203,313,000 | -3.1% | 55,702 | +11.7% | 0.00% | 0.0% |
Q1 2014 | $209,864,000 | -6.2% | 49,849 | +2.5% | 0.00% | 0.0% |
Q4 2013 | $223,799,000 | -26.4% | 48,652 | -1.0% | 0.00% | -50.0% |
Q3 2013 | $304,177,000 | +12.6% | 49,140 | -1.1% | 0.00% | 0.0% |
Q2 2013 | $270,199,000 | – | 49,669 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |